Literature DB >> 19084485

Glucocorticoids and neuro- and behavioural development.

Ana Raquel Mesquita1, Yvonne Wegerich, Alexandre V Patchev, Mario Oliveira, Pedro Leão, Nuno Sousa, Osborne F X Almeida.   

Abstract

Epidemiological evidence links exposure to stress hormones during fetal or early postnatal development with lifetime prevalence of cardiac, metabolic, auto-immune, neurological and psychiatric disorders. This has led to the concept of 'developmental programming through stress'. Importantly, these effects (specifically, hypertension, hyperglycaemia and neurodevelopmental and behavioural abnormalities) can be reproduced by exposure to high glucocorticoid levels, indicating a crucial role of glucocorticoids in their causation. However, there can be important differences in outcome, depending on the exact time of exposure, as well as duration and receptor selectivity of the glucocorticoid applied. The mechanisms underlying programming by stress are still unclear but it appears that these environmental perturbations exploit epigenetic modifications of DNA and/or histones to induce stable modifications of gene expression. Programming of neuro- and behavioural development by glucocorticoids and stress are important determinants of lifetime health and should be a consideration when choosing treatments in obstetric and neonatal medicine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084485     DOI: 10.1016/j.siny.2008.11.002

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  15 in total

1.  The influence of early life interventions on olfactory memory related to palatable food, and on oxidative stress parameters and Na+/K+-ATPase activity in the hippocampus and olfactory bulb of female adult rats.

Authors:  Cristie Noschang; Rachel Krolow; Danusa M Arcego; Daniela Laureano; Luiza D Fitarelli; Ana Paula Huffell; Andréa G K Ferreira; Aline A da Cunha; Fernanda Rossato Machado; Angela T S Wyse; Carla Dalmaz
Journal:  Neurochem Res       Date:  2012-05-10       Impact factor: 3.996

2.  The bed nucleus of stria terminalis and the amygdala as targets of antenatal glucocorticoids: implications for fear and anxiety responses.

Authors:  Mário Oliveira; Ana-João Rodrigues; Pedro Leão; Diana Cardona; José Miguel Pêgo; Nuno Sousa
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

3.  Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors.

Authors:  Stefanie L Bronson; Rebecca Ahlbrand; Paul S Horn; Joseph R Kern; Neil M Richtand
Journal:  Behav Brain Res       Date:  2011-01-19       Impact factor: 3.332

4.  Candidate placental biomarkers for intrauterine alcohol exposure.

Authors:  Pradeep K Shukla; Laura J Sittig; Timothy M Ullmann; Eva E Redei
Journal:  Alcohol Clin Exp Res       Date:  2010-12-08       Impact factor: 3.455

5.  Timing of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies.

Authors:  Quetzal A Class; Paul Lichtenstein; Niklas Långström; Brian M D'Onofrio
Journal:  Psychosom Med       Date:  2011-02-14       Impact factor: 4.312

6.  Prenatal stress induces spatial memory deficits and epigenetic changes in the hippocampus indicative of heterochromatin formation and reduced gene expression.

Authors:  Jamie D Benoit; Pasko Rakic; Karyn M Frick
Journal:  Behav Brain Res       Date:  2014-12-08       Impact factor: 3.332

7.  Differential subcellular localization of the glucocorticoid receptor in distinct neural stem and progenitor populations of the mouse telencephalon in vivo.

Authors:  Maria A Tsiarli; A Paula Monaghan; Donald B Defranco
Journal:  Brain Res       Date:  2013-06-07       Impact factor: 3.252

8.  Interplay between Depressive-Like Behavior and the Immune System in an Animal Model of Prenatal Dexamethasone Administration.

Authors:  Susana Roque; Tiago Gil Oliveira; Claudia Nobrega; Palmira Barreira-Silva; Cláudio Nunes-Alves; Nuno Sousa; Joana Almeida Palha; Margarida Correia-Neves
Journal:  Front Behav Neurosci       Date:  2011-02-07       Impact factor: 3.558

9.  The positive effect on ketamine as a priming adjuvant in antidepressant treatment.

Authors:  A Melo; N Kokras; C Dalla; C Ferreira; A P Ventura-Silva; N Sousa; J M Pêgo
Journal:  Transl Psychiatry       Date:  2015-05-26       Impact factor: 6.222

10.  Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axis.

Authors:  Tara K S Craft; A Courtney Devries
Journal:  Front Behav Neurosci       Date:  2009-12-09       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.